Sunshine Biopharma Announces Reverse Stock Split

August 6, 2024 8:00 AM

Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, announced today a one for twenty reverse split of its common stock, effective at market open on August 8, 2024. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for...

Read more

Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology

August 6, 2024 8:00 AM

FORT MILL, SC / ACCESSWIRE / August 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today the publication of its first LockeT study in the Journal of Cardiovascular Electrophysiology. The study titled, Feasibility, safety and efficacy of a novel external compression vascular closure device: The LockeT Study, was made available online on August 5, 2024.The study demonstrates the...

Read more

Ainos Concludes Growth Financing From Lind Partners

August 6, 2024 7:30 AM

Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose interferon therapeutics ("VELDONA"), today announced that the Company has prepaid its remaining convertible note financing (the "Note") with Lind Global Fund II LP, an institutional investment fund managed by The Lind Partners (together the "Investor"), through conversions of the...

Read more

Acreage Commences Non-Medical Cannabis Sales in Ohio

August 6, 2024 7:00 AM

Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U)(CSE:ACRG.B.U)(OTCQX:ACRHF)(OTCQX:ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today announced the launch of non-medical cannabis sales in Ohio. Beginning today, non-medical consumers in Ohio who are 21+ can purchase cannabis products from The Botanist locations in Akron, Canton, Cleveland, Wickliffe, and...

Read more

Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update

August 6, 2024 7:00 AM

Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the second quarter ended June 30, 2024, and provided a corporate update."During the second quarter of 2024 our team made tremendous strides in the late-stage clinical development of rusfertide and also in leveraging our proprietary discovery platform for early-stage, but highly differentiated, oral peptides-based discovery programs," said...

Read more

Ainos Reports Second Quarter 2024 Financial Results

August 5, 2024 4:15 PM

Enrolling first subject for FCGS clinical study marks a solid start in shifting animal health emphasis to drug developmentsRobust financial runway for over 12 months following the prepayment of a senior secured convertible noteSAN DIEGO, CA / ACCESSWIRE / August 5, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and low-dose...

Read more

Houston Medical Waste Disposal Company Tackles Piercing Surge in Needlestick Injuries With Essential Guide

August 5, 2024 2:30 PM

The CDC has reported an estimated 385,000 incidents of needlestick and sharps-related injuries among healthcare workers annually in the U.S.HOUSTON, TX / ACCESSWIRE / August 5, 2024 / With the number of needlestick injuries reaching concerning levels, BioMedical Waste Solutions, a prominent national provider of medical waste disposal services headquartered in Houston, TX, is proactively working to educate the public on the dangers of improperly...

Read more

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results

August 5, 2024 10:18 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 5, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today issued a letter to shareholders from the company's founder, president, and chief executive officer, Lisa Conte.Dear Fellow Shareholders,Jaguar will be hosting a webcast, providing a review of earnings for the second quarter of 2024, at 8:30 a.m. Eastern on Tuesday, August 13, 2024. We will also further review the data and regulatory strategy for...

Read more

Transforming Aesthetics: Dr. Maria Fedchuk's Journey of Innovation at MTS US

August 5, 2024 10:00 AM

BEVERLY HILLS, CA / ACCESSWIRE / August 5, 2024 /Another unique product received international recognition at the same Congress- RADIANCE from PEELING SYSTEM (Dermoaroma, Italy) was honored with an "Aesthetic Medicine Award" in the nomination "the Best Aesthetic Product and Device Integration". The entire scientific reasoning of the uniqueness of the system and the patients' results were applied by Dr. Fedchuk. Every step of the unique...

Read more

Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access

August 5, 2024 10:00 AM

Vascular Therapies, a biotechnology company focused on improving vascular access outcomes in patients with kidney disease, today announced completion of enrollment in the ACCESS 2 trial, a Phase III prospective randomized, multicenter clinical study of Sirogen™ for the surgical creation of arteriovenous (AV) fistula in patients requiring hemodialysis vascular access.Vascular Therapies is developing a proprietary sirolimus formulation (Sirogen)...

Read more

IntoValue, Inc, Welcomes Steve Nelson to Board of Directors

August 5, 2024 9:45 AM

IntoValue, Inc., a groundbreaking healthcare direct-to-employer technology enablement company, proudly announces the appointment of Steve Nelson to its Board of Directors.WASHINGTON, DC / ACCESSWIRE / August 5, 2024 / IntoValue, Inc., a groundbreaking healthcare direct-to-employer technology enablement company, proudly announces the appointment of Steve Nelson to its Board of Directors.Steve Nelson brings tremendous executive leadership...

Read more

Latino Community Fund (LCF Georgia) Announces 'Estamos Aquí Fiesta' to Kick Off Hispanic/Latinx Heritage Month

August 5, 2024 9:30 AM

"Estamos Aquí Fiesta 2024": Celebrating Hispanic Heritage Month with an Exciting Lineup from the Latino Community Fund GeorgiaATLANTA, GA / ACCESSWIRE / August 5, 2024 / The Latino Community Fund (LCF Georgia) is thrilled to announce its annual "Estamos Aquí Fiesta 2024," a vibrant, free, family-friendly festival celebrating Hispanic/Latinx Heritage Month. The event will take place at Historic Old Fourth Ward Park Amphitheater on September 7,...

Read more

Dr. Xieng Lee, DDS is Featured in an Exclusive Interview with Infinite Sights

August 5, 2024 8:45 AM

Dr. Xieng K. Lee, a renowned dentist and community advocate based at Quality Dental Care in Brooklyn Park, MN, was recently featured in a comprehensive interview with Infinite Sights. The interview offers insights into Dr. Lee's unique approach to dental care, his commitment to sustainability, and his innovative use of technology in dentistry.In the interview, Dr. Lee shares how his upbringing in a refugee camp and his journey as an immigrant...

Read more

BIO-Europe(R) Celebrates 30th Anniversary with Landmark Event in Stockholm

August 5, 2024 8:15 AM

Join the 30th anniversary edition of BIO-Europe®, the premier biopharma partnering event that has grown with the industry, continually innovating and remaining the hub for impactful conversations and connections. Following a record-breaking 2023, the 2024 event promises even greater opportunities for connection and partnering.The 30th annual BIO-Europe will be held from November 4-6, 2024, in Stockholm, Sweden. This year's event is set to...

Read more

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

August 5, 2024 8:00 AM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the appointment of Thomas P. Davis, MD, FACC, as Chief Medical Officer for its peripheral business. As a highly experienced interventional cardiologist and key opinion leader (KOL) in the peripheral vascular space, Dr. Davis has...

Read more

Relief Therapeutics Secures up to $11 Million from Royalty Sales

August 5, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the signing and closing of a definitive agreement with SWK Funding LLC (SWK), a wholly-owned subsidiary of SWK Holdings Corporation, for the sale of royalty interests in OLPRUVA®, GOLIKE® and CAMBIA® in exchange...

Read more

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment

August 2, 2024 4:10 PM

CHICAGO, IL / ACCESSWIRE / August 2, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT®) applauds the U.S. Food and Drug Administration's (FDA) accelerated approval of TECELRA® (afamitresgene autoleucel) for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy. This groundbreaking therapy offers a new treatment option for patients with this rare, soft tissue...

Read more

KARE PharmTech Hosts Empowered Pharmacies Futures Summit to Transform Community Pharmacies

August 2, 2024 3:00 PM

KARE PharmTech: Empowering Physicians, Pharmacists, and Patients to Improve Patient CareTAMPA, FL / ACCESSWIRE / August 2, 2024 / KARE PharmTech announces the successful conclusion of the Empowered Pharmacies Futures Summit, held on July 28 and 29, 2024, in Tampa, Florida. This landmark event signifies a major milestone in KARE's mission to revolutionize the healthcare landscape by empowering independent community pharmacies to compete and...

Read more

Neighborhood LTC Pharmacy Announces New Technology Partnership With Impruvon Health

August 2, 2024 12:00 PM

LINCOLN, NE / ACCESSWIRE / August 2, 2024 / Neighborhood LTC Pharmacy, a leader in pharmacy services for individuals with Intellectual and Developmental Disabilities (IDD), is thrilled to announce a new technology partnership with Impruvon Health. This collaboration introduces new options to Neighborhood LTC Pharmacy customers, including technology aimed at enhancing the quality of life for individuals by promoting independence and improving...

Read more

Biden-Harris-DEA Marijuana Scam - MMJ's Legal Actions Proceed in Federal Court

August 2, 2024 11:15 AM

WASHINGTON, DC / ACCESSWIRE / August 2, 2024 / In recent social media posts, the Democratic National Committee (DNC) claimed that the Biden administration had "reclassified marijuana" and ended the "failed approach to marijuana," symbolized with green checkmark emojis.However, Tim Moynahan, lawyer and chairman of MMJ BioPharma Cultivation, criticized these claims, emphasizing that actions are more significant than words. MMJ BioPharma...

Read more